Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A288904
Tue, 25.06.2024
CompuGroup Medical SE & Co. KGaA
Today, Profdoc AS, a 100% subsidiary of CompuGroup Medical SE & Co. KGaA, has entered into an agreement with the shareholders of Pridok AS to acquire 100% of the shares in Pridok AS.
Pridok AS with its corporate seat in Tønsberg, Norway, offers a web-based digital patient journal system for the healthcare sector. In the financial year 2023, it [ … ]
Tue, 18.06.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical acquires AmbulApps
Koblenz - CompuGroup Medical acquires AmbulApps GmbH, a specialist in digital anamnesis tools. Founded in Neuss in 2015, the company organizes, digitizes and structures the collection of data from and about patients. CompuGroup Medical will integrate AmbulApps' applications into its portfolio of solutions an [ … ]
Wed, 22.05.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00
Acts of the governing boards formally approved
Dividend proposal of EUR 1.00 confirmed
High approval rates for capital measures
Focus on data-based solutions and artificial intelligence
Koblenz - The shareholders of CompuGroup Medical SE & Co. [ … ]
Wed, 08.05.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical with solid first quarter against strong prior year
Revenues down by 2%, organic growth of 3% adjusted for TI one-offs
Recurring revenue share increases to 75%
Advancing digitization in German and French healthcare
Continuing revenue conversion of hospital order backlog
Leverage reduced to 2.6x
Koblenz - At CompuGroup Medic [ … ]
Wed, 08.05.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical with solid first quarter against strong prior year
Revenues down by 2%, organic growth of 3% adjusted for TI one-offs
Recurring revenue share increases to 75%
Advancing digitization in German and French healthcare
Continuing revenue conversion of hospital order backlog
Leverage reduced to 2.6x
Koblenz - At CompuGroup Medic [ … ]
Mon, 29.04.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical successfully completes share buyback program
Target reached before expiration date
Company acquires 500,000 shares
Volume of EUR 14.6 million
Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) has ended its share buyback program successfully on April 26 shortly before the expiration date. The target of a maximum of 500,000 [ … ]
Mon, 29.04.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical successfully completes share buyback program
Target reached before expiration date
Company acquires 500,000 shares
Volume of EUR 14.6 million
Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) has ended its share buyback program successfully on April 26 shortly before the expiration date. The target of a maximum of 500,000 [ … ]
Wed, 10.04.2024
CompuGroup Medical SE & Co. KGaA
CGM proposes dividend of EUR 1.00 to be passed at virtual AGM in May
Virtual Annual General Meeting on May 22, 2024
Agenda for the AGM published
Dividend doubled to EUR 1.00
Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) will hold its Annual General Meeting on May 22 again virtually this year. The virtual AGM format will enable a direc [ … ]
Mon, 25.03.2024
CompuGroup Medical SE & Co. KGaA
The general partner of CompuGroup Medical SE & Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890), utilizing the authorization granted by its annual general meeting of May 19, 2021 pursuant to section 71(1) no. 8 of the German Stock Corporation Act (Aktiengesetz), resolved today to buy back a maximum number of up to 500,000 shares of t [ … ]
Mon, 25.03.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical US announces CEO transition
Austin, TX – Underlining the commitment to its second largest market worldwide by revenue, CompuGroup Medical announces the appointment of Benedikt Brueckle as its new Chief Executive Officer for the US, effective January 1, 2025. Benedikt Brueckle is a respected and experienced leader in the healt [ … ]